The search combined controlled vocabulary (e.g., MeSH terms) and free-text keywords relating to “GLP-1 receptor agonist,” “diabetic retinopathy,” and “diabetic nephropathy.” Reference lists of relevant reviews and included studies were hand-searched to identify additional eligible trials. Here, GLP1R is linked to diabetic kidney disease.